Patient Guide: A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 49 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT01896479
Status: ACTIVE_NOT_RECRUITING
Condition: Medullary Thyroid Cancer
Phase: PHASE4

Find a Study Location Near You

This study is available at 49 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • St Leonards, New South Wales
  • Herston, Queensland
  • Kurralta Park, South Australia
  • • And 46 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily